SEC Filing Summary for IDEAYA Biosciences, Inc. - Form 4 Filing

This Form 4 filing details a transaction by Scott W. Morrison, a director at IDEAYA Biosciences, Inc. (IDYA). On June 16, 2026, Morrison was granted 20,000 stock options with an exercise price of $30.57 per share. These options are exercisable for IDEAYA’s Common Stock. The options vest fully on the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant date, provided Morrison remains in service. The filing also notes that 100% of the shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or immediately prior to the Annual Meeting following the date of grant, subject to the Reporting Person continuing in service on the Board through such vesting date. The transaction was reported on June 18, 2026.